Related Articles |
Comparison of 4 FDA-approved mechanical thrombectomy devices for acute ischemic stroke: a network meta-analysis.
World Neurosurg. 2019 Feb 22;:
Authors: Deng L, Qiu S, Wang L, Li Y, Wang D, Liu M
Abstract
BACKGROUND: The use of mechanical thrombectomy for the treatment of acute ischemic stroke (AIS) is rapidly growing. However there are limited data on the comparative effects of the various devices approved by the FDA for the treatment of AIS. We aimed to perform a network meta-analysis to assess the relative efficacy and safety of 4 thrombectomy devices.
METHODS: We searched PubMed, the Cochrane Library Central Register of Controlled Trials, Embase for randomized controlled trials (RCTs) and parallel group observational studies which assessed thrombectomy devices in patients with AIS. Primary efficacy outcomes included functional independence (90-day modified Rankin Scale [mRS] score) and recanalization rate (thrombolysis in cerebral infarction [TICI score]). Safety outcomes included incidence of symptomatic intracranial hemorrhages (sICH) and 90-day mortality.
RESULTS: 5 RCTs and 5 observational studies, including 1659 participants were included. According to GRADE, most of the studies are of moderate evidence quality. Compared with Penumbra, Solitaire and Trevo were associated with higher rates of functional independence (3.75[1.44, 7.66]; 4.68[1.42,11.50], respectively). For revascularization, Solitaire and Trevo had higher rates of successful recanalization than Merci (2.99[1.15,6.53]; 3.34[1.20,8.01], respectively). In terms of safety outcomes (sHT and mortality), there was no significant difference between any comparators.
CONCLUSIONS: We concluded that stent-retriever devices were superior to non-stent retriever devices in functional outcomes and recanalization without significant increases in death or symptomatic hemorrhage. We found no evidence for a differential therapy effect by stent type. Further high-quality RCTs assessing efficacy difference between these two stent-retrievers are justified.
PMID: 30802552 [PubMed - as supplied by publisher]
from A via a.sfakia on Inoreader https://ift.tt/2TlBixG
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου
Medicine by Alexandros G. Sfakianakis,Anapafseos 5 Agios Nikolaos 72100 Crete Greece,00302841026182,00306932607174,alsfakia@gmail.com,